Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L.I.A. Pure Capital is a private Israeli investment company based in Tel Aviv, operating in financial services rather than biotechnology or healthcare. Public business-profile and regulatory sources describe it as an investment company/asset manager, and investment databases also categorize it as a placement-agent-style financing organization. Its visible public footprint is primarily through ownership and beneficial-interest filings and portfolio disclosures, rather than through drug development, clinical programs, or healthcare products. Although it may invest in healthcare or biotech issuers from time to time, L.I.A. Pure Capital itself does not appear to be a life sciences operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L.I.A. Pure Capital.